Crossmark

Diabetes fulminante secundaria a tratamiento con pembrolizumab

Crossref DOI link: https://doi.org/10.1016/j.endinu.2017.01.005

Published Print: 2017-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Mizab Mellah, Chadia

Sánchez Pérez, Marta

Santos Rey, María Dolores

Hernández García, Marta
License Information

Text and Data Mining valid from 2017-05-01
More Information

This article is maintained by: Elsevier

Article Title: Diabetes fulminante secundaria a tratamiento con pembrolizumab

Journal Title: Endocrinología, Diabetes y Nutrición

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.endinu.2017.01.005

Content Type: simple-article

Copyright: © 2017 SEEN. Published by Elsevier España, S.L.U. All rights reserved.